908 Devices (MASS)
Builds handheld instruments that identify hazardous chemicals at the point of need.
Something off on this page? Send us feedback.
Sells handheld mass spectrometry and spectroscopy devices, plus software, service, and subscriptions, to government, public-safety, defense, customs, and selective life-sciences users. The portfolio is concentrated in field chemical detection after the desktop bioprocessing sale.
Builds point-of-need chemical analyzers used when field teams need rapid answers outside a lab. Current products include MX908 mass spectrometry devices, FTIR devices named ThreatID, ProtectIR and XplorIR, VipIR multi-technology analysis, and NIRLAB near-infrared narcotics tools.
Sales run worldwide through direct teams and channel partners, with demand centered on government, public-safety, defense, law-enforcement, customs, border-protection and related life-sciences users. The operating model is one consolidated segment, supported by manufacturing and testing in Connecticut and precision-machining capabilities that help secure FTIR components.
The business depends on public-sector budgets, government-contract compliance, export controls, cybersecurity requirements, and specialized components. The desktop bioprocessing portfolio has been sold, so the current portfolio is field and handheld chemical detection.
Company facts
Categories
Unavailable right now.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $101.5M · Total debt $4.3M · Total assets $197.5M · Shareholders' equity $126.8M
- Revenue
- $16.1M
- Operating income
- −$12.8M
- Net income
- −$11.9M
No dividends on record.
| Institutions114 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | ≈ 68.48% | 28.31M shares | |
| Insiders14 holders · as of Aug 27, 2026 | 6.18% | 2.56M shares | |
| Strategic holders2 holders · as of May 15, 2026 | 22.22% | 9.18M shares | |
| Otherremainder | ≈ 3.12% | 1.29M shares |
41.33M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
First Light Asset Management, LLCInstitution | 15.20% | 6.28M | 13Fas of Jun 30, 2026 |
ARCH Venture Fund VII, L.P.Strategic10 percent owner | 13.85% | 5.73M | 13Gfiled May 15, 2026 ↗ |
AWM Investment Company, Inc.Institution | 11.81% | 4.88M | 13Fas of Jun 30, 2026 |
Alger Associates, Inc.Strategic | 8.37% | 3.46M | 13Gfiled Oct 11, 2022 ↗ |
Ark Investment Management LLCInstitution | 4.91% | 2.03M | 13Fas of Jun 30, 2026 |
| See all 25 → | |||
13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 25, 2026 | Joseph H. IV Griffith | officer: Chief Financial Officer | −11,459 | $10.95 |
| Aug 21, 2026 | AWM Investment Company, Inc. | 10 percent owner | −41,578 | $10.61 |
| Aug 20, 2026 | AWM Investment Company, Inc. | 10 percent owner | −8,422 | $10.52 |
| Aug 17, 2026 | Kevin J. Knopp | director, officer: President and CEO | −20,000 | $10.35 |
| Aug 13, 2026 | Kevin J. Knopp | director, officer: President and CEO | −7,622 | $10.06 |
- Thermo Fisher Scientific
Handheld Raman/FTIR and narcotics analyzers for public-safety users
- Teledyne Technologies
Portable GC/MS and explosives trace detection for defense and responders
- Agilent Technologies
Through-barrier Raman and handheld FTIR for field chemical ID
- Bruker
CBRNE detection systems and mobile GC/MS for defense customers
- MSA
Portable gas detection and connected safety tools for hazmat teams
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| 908 Devices | $10.34 | −2.91% | $423.8M | — | — | 7.0 | +23.3% |
| Thermo Fisher Scientific | $609.99 | +0.25% | $226.15B | 32.7 | 23.2 | 4.9 | +10.5% |
| Teledyne Technologies | $607.00 | +0.04% | $28.11B | 29.3 | 23.8 | 4.4 | +9.8% |
| Agilent Technologies | $152.51 | +0.76% | $42.76B | 29.8 | 23.0 | 5.8 | +8.1% |
| Bruker | $60.00 | +1.61% | $8.98B | — | 26.1 | 2.6 | +5.2% |
| MSA | $188.53 | −0.04% | $7.28B | 23.4 | 19.6 | 3.7 | +6.2% |
| Median | 29.5 | 23.2 | 4.4 | +8.1% |